by Editorial Team | 1 Feb, 2022 | Acthera, LinkedIn, NEWS
Acthera has appointed Thierry Fumeaux as CEO beginning February 2022. He started in April 2021 as the company’s Chief Medical Officer, and Co-CEO in September 2021. Pierre-Alain Monnard will be the CSO (Chief Science Officer) of the Company. … Read more >...
by Editorial Team | 6 Jul, 2021 | Acthera, NEWS
Basel, July 6, 2021 Acthera Therapeutics AG, a biopharmaceutical company developing an innovative targeted release technology platform, announced today the successful completion of a CHF 5.4 million Seed A financing round. In addition, the company managed to secure...